Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line.

PURPOSE Resveratrol (Calbiochem, La Jolla, California) is a naturally occurring stilbene reported to cause apoptosis in various cultured cancer cells. In the current study the effect of resveratrol was determined in the androgen insensitive DU 145 prostate cancer cell line. Induction of apoptosis and activation of apoptosis related signal transduction pathways were measured. MATERIALS AND METHODS DU 145 cells were treated with resveratrol and apoptosis was measured by determining nucleosome content. Activation of mitogen activated protein kinase (MAPK) (extracellular signal-regulated kinase 1/2), p53 content and serine-15 phosphorylation of p53 were measured by immunoblot. Electrophoretic mobility shift assay of p53 binding to DNA, and measurement of p21 and glyceraldehyde-3-phosphate dehydrogenase messenger RNA were also done. RESULTS Resveratrol induced apoptosis in DU 145 cells. The stilbene activated MAPK and caused increased abundance of p53 and serine-15 phosphorylated p53. Resveratrol induced serine-15 phosphorylation of p53 was blocked by PD 98059 (Calbiochem), a MAPK kinase inhibitor, implicating MAPK activation in the phosphorylation of p53. PD 98059 also inhibited resveratrol induced apoptosis. These results suggest that apoptosis induction by resveratrol in DU 145 cells requires serine-15 phosphorylation of p53 by MAPK. Inhibition of MAPK dependent serine-15 phosphorylation resulted in reduced p53 binding to a p53 specific oligonucleotide on electrophoretic mobility shift assay. Pifithrin-alpha (Calbiochem), a p53 inhibitor, blocked resveratrol induced serine-15 phosphorylation of p53 and p53 binding to DNA. Resveratrol caused a p53 stimulated increase in p21 messenger RNA. Transfection of additional wild-type p53 into DU 145 cells induced apoptosis, which was further enhanced by resveratrol treatment. CONCLUSIONS Resveratrol causes apoptosis in DU 145 prostate cancer cells. This action depends on the activation of MAPK, increase in cellular p53 content, serine-15 phosphorylation of p53 and increased p53 binding to DNA.

[1]  L. Kerr,et al.  Electrophoretic mobility shift assay. , 1995, Methods in enzymology.

[2]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[3]  L. Riley,et al.  Reverse transcriptase polymerase chain reaction (RT-PCR). , 2000, Contemporary topics in laboratory animal science.

[4]  K. Vousden,et al.  p53 in signaling checkpoint arrest or apoptosis. , 1996, Current opinion in genetics & development.

[5]  P. Howley,et al.  Mutations in serines 15 and 20 of human p53 impair its apoptotic activity , 1999, Oncogene.

[6]  W. Isaacs,et al.  Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. , 1991, Cancer research.

[7]  F. B. Davis,et al.  Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. , 1999, American journal of physiology. Cell physiology.

[8]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[9]  F. B. Davis,et al.  Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. , 2001, Biochemistry.

[10]  J. Isaacs,et al.  Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer , 1996, The Prostate.

[11]  Yoichi Taya,et al.  Regulation of p53 by Hypoxia: Dissociation of Transcriptional Repression and Apoptosis from p53-Dependent Transactivation , 2001, Molecular and Cellular Biology.

[12]  E. Appella,et al.  p53 Regulates the Expression of the Tumor Suppressor Gene Maspin* , 2000, The Journal of Biological Chemistry.

[13]  M. Hande,et al.  DNA Strand Break-Sensing Molecule Poly(ADP-Ribose) Polymerase Cooperates with p53 in Telomere Function, Chromosome Stability, and Tumor Suppression , 2001, Molecular and Cellular Biology.

[14]  W. Dercks,et al.  Influence of fosetyl-Al on phytoalexin accumulation in the Plasmopara viticola-grapevine interaction , 1989 .

[15]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[16]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[17]  F. B. Davis,et al.  Thyroid hormone promotes the phosphorylation of STAT3 and potentiates the action of epidermal growth factor in cultured cells. , 1999, The Biochemical journal.

[18]  S. Srivastava,et al.  Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53. , 1993, Oncogene.

[19]  T. McDonnell,et al.  Implications of cell death regulation in the pathogenesis and treatment of prostate cancer. , 1999, Seminars in oncology.

[20]  T. Hsieh,et al.  Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism. , 2000, Anticancer research.

[21]  L. Frémont.  Biological effects of resveratrol. , 2000, Life sciences.

[22]  T. Hsieh,et al.  Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. , 1999, Experimental cell research.

[23]  C. Culmsee,et al.  A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide , 2001 .

[24]  E. Sugikawa,et al.  Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53. , 1999, Biochemical and biophysical research communications.

[25]  E. Castanas,et al.  Wine Antioxidant Polyphenols Inhibit the Proliferation of Human Prostate Cancer Cell Lines , 2000, Nutrition and cancer.

[26]  A. Boninsegna,et al.  Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. , 2001, Mutation research.

[27]  L. Penn.  Apoptosis modulators as cancer therapeutics. , 2001, Current opinion in investigational drugs.

[28]  M L Agarwal,et al.  The p53 Network* , 1998, The Journal of Biological Chemistry.

[29]  Hung-Yun Lin,et al.  Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. , 2002, The Journal of clinical endocrinology and metabolism.

[30]  Weiya Ma,et al.  Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. , 2001, Cancer research.

[31]  C. Marshall,et al.  Oncogenes and cell proliferation. , 1996, Current opinion in genetics & development.

[32]  Hung-Yun Lin,et al.  Thyroxine Promotes Association of Mitogen-activated Protein Kinase and Nuclear Thyroid Hormone Receptor (TR) and Causes Serine Phosphorylation of TR* , 2000, The Journal of Biological Chemistry.

[33]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[34]  M. Kubbutat,et al.  Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.

[35]  V. Rotter,et al.  Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. , 2000, Cancer research.

[36]  P. D. Lee,et al.  Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. , 1995, Human molecular genetics.